Document:

Exhibit 10-U

 

EMPLOYMENT AND NONCOMPETITION AGREEMENT

 

This EMPLOYMENT AND NONCOMPETITION AGREEMENT
(the "Agreement") is made and entered into as of the 4th day of December, 2012, by and between SHOE CARNIVAL, INC.,
an Indiana corporation with its principal offices located at 7500 East Columbia Street, Evansville, Indiana (the "Company"),
and CARL N. SCIBETTA, an individual residing at 4252 Birkshire Heights, Fort Mill, South Carolina (the "Employee").

 

RECITALS

 

WHEREAS, the Company is one of the
leading retailers of family shoes in the United States; and

 

WHEREAS, the Company desires to retain
the services of the Employee upon the terms and conditions set forth herein; and

 

WHEREAS, the Employee desires to
be so employed by the Company, to be eligible for opportunities of advancement, potential compensation increases and the potential
payments provided for herein; and

 

WHEREAS, the Company and the Employee
desire to enter into this Agreement to set forth the terms and conditions of the employment relationship between the Company and
the Employee; and

 

WHEREAS, in connection with its business,
the Company has expended a substantial amount of time, money, and effort to develop and maintain its confidential, proprietary
and trade secret information, and that this information, if misused or disclosed, could be very harmful to Company’s business
and its competitive position in the marketplace.

 

AGREEMENT

 

1.          Term
of Employment. The Company hereby agrees to employ Employee and Employee hereby agrees to be employed by the Company, in
accordance with the terms and conditions herein, for a period commencing on the effective date of this Agreement up to and through
January 31, 2014, subject, however, to earlier termination as expressly provided in this Agreement (such term, including any extension
thereof, shall herein be referred to as the "Term"). This Agreement shall be renewed automatically for successive terms
of one (1) year each unless either party provides written notice of non-renewal to the other party not more than ninety (90) days
and not less than thirty (30) days before the end of the then current Term. 

 

    	 

    	 

    

 

2.          Scope
of Duties. The Employee shall serve in the position of Executive Vice President, General Merchandise Manager. During the
Term, the Employee agrees to perform such other services for the Company as may be directed by any superior officer of the Company,
and to assume such other title, duties, and/or responsibilities as the Board of Directors may determine. The Employee shall be
supportive of the Company's business and its best interests and shall not, directly or indirectly, take any action which could
reasonably be expected to have an adverse effect upon the business or best interests of the Company. The Employee covenants that
he will at all times honestly and fairly conduct his duties, and will at all times maintain the highest of professional standards
in representing the interests of the Company. The Employee will comply with Company policies, decisions, and instructions, which
may be changed by the Company over time. Employee shall perform all duties incident to his position, as well as any other duties
as may from time to time be assigned by the President of the Company or his designee, and agrees to abide by all By-laws, policies,
practices, procedures or rules of the Company.

 

3.          Compensation
of Employee. For all services rendered by the Employee under this Agreement, the Company shall compensate the Employee
as follows:

 

3.1           Base
Salary. The base salary payable to the Employee under this Agreement shall be that amount of base salary payable as of
the effective date of this Agreement ("Base Salary"), payable in accordance with the Company's usual payroll procedures,
and subject to all taxes, withholdings and deductions as required by law and as the Employee may authorize. The Company will review
the Base Salary on a periodic basis, approximately annually, during the Term to determine, in the discretion of the Company, whether
the Base Salary should be adjusted, and if so, the amount of such adjustment and the time at which such adjustment should take
effect.

 

3.2           Incentive
Bonus. The Employee is entitled to participate in the Company’s 2006 Executive Incentive Compensation Plan, as amended,
in accordance with the terms contained therein, and in any successor plan adopted by the Company from time to time. However, Employee
agrees that the failure of the Company to award any such bonus and/or other incentive compensation shall not give rise to any claim
against the Company.

 

4.          Additional
Compensation, Benefits, and Obligations. During the Term, and so long as the Employee serves in the position of Executive
Vice President, Employee is entitled to participate in any and all employee welfare and health benefit plans (including, but not
limited to, life insurance, health and medical, dental and disability plans, and executive supplemental medical coverage) and other
employee benefit plans, including but not limited to, qualified pension plans, stock purchase plans, and nonqualified deferred
compensation plans, established by the Company from time to time for the benefit of executives at his level and position; provided,
however, the Employee's participation in such plans is subject to the eligibility requirements and other terms of such plans. The
Company may change, amend or discontinue any of its employee welfare and health benefit plans at any time during the Term, and
nothing in this Agreement shall obligate the Company to institute, maintain or refrain from changing, amending or discontinuing
any such plans or programs.

 

5.          Termination
of Employment. Employee’s employment may be terminated as follows:

 

    	-2-

    	 

    

 

5.1           For
Cause. The Company may terminate Employee’s employment at any time effective immediately for "Cause." As
used in this Agreement, the term "Cause" means the occurrence of any one or more of the following events: (i) Employee's
conviction for a felony or other crime involving moral turpitude; (ii) Employee's engaging in illegal conduct or gross misconduct
which is injurious to the Company; (iii) Employee's engaging in any fraudulent or dishonest conduct in his dealings with,
or on behalf of, the Company; (iv) Employee's failure or refusal to follow the lawful and reasonable instructions of the Company's
Chief Executive Officer, President, or other executive officer to whom Employee reports, if such failure or refusal continues for
a period of ten (10) days after the Company delivers to Employee a written notice stating the instructions which Employee has failed
or refused to follow; (v) Employee's material breach of any of his obligations under this Agreement; (vi) Employee's material breach
of the Company's policies; (vii) Employee's use of alcohol or drugs which interferes with the performance of his duties for the
Company or which compromises the integrity or reputation of the Company; or (viii) Employee's engaging in any conduct tending to
bring the Company into public disgrace or disrepute.

 

5.2           Unilateral
– The Company. The Company may terminate Employee’s employment at any time without Cause.

 

5.3           Unilateral
- Employee. Employee may terminate his employment at any time with the Company by providing the Company with thirty (30)
days' advance written notice of such termination. At the sole option of the Company, such termination will be considered effective
on the date such notice is given.

 

5.4           For
Good Reason - Employee. At any time during the Term, Employee may terminate this Agreement for Good Reason if all of the
following conditions are satisfied: (a) Employee gives the Company a written notice of termination, which describes in reasonable
detail the condition claimed to constitute Good Reason, within thirty (30) calendar days of the initial existence of the condition
claimed to constitute Good Reason; (b) the Company does not remedy the condition within thirty (30) calendar days of the Company’s
receipt of Employee’s written notice of termination (the “Good Reason Cure Period”); and (c) Employee gives the
Company a second written notice of termination within thirty (30) calendar days following the expiration of the Good Reason Cure
Period. For purposes of this Agreement, for “Good Reason" means the occurrence, without Employee’s written consent,
of a material reduction by the Company in Employee’s Base Salary. Termination of this Agreement without Cause or for
Good Reason shall not be deemed to be a voluntary termination by Employee for purposes of any stock option or equity incentive
plans of the Company.

 

    	-3-

    	 

    

 

5.5           Disability
or Death. If Employee suffers a "Disability," the Company shall have the right to terminate Employee's employment
by delivering to Employee a written notice of the Company's intent to terminate for Disability, specifying in such notice a termination
date not less than ten (10) calendar days after the giving of the notice (the "Disability Notice Period"). The Employee's
employment shall terminate at the close of business on the last day of the Disability Notice Period. For purpose of this Agreement,
the term "Disability" shall mean either (a) when Employee is deemed disabled in accordance with the long-term disability
insurance policy or plan of the Company in effect at the time of the illness or injury causing the Disability, or (b) the
inability of Employee, because of injury, illness, disease or bodily or mental infirmity, to perform the essential functions of
his job (with reasonable accommodation) for more than one hundred twenty (120) consecutive days. The existence of a Disability
shall be determined by the Company. If the Employee should die during the Term, this Agreement shall terminate as of the date of
Employee's death.

 

5.6           Compensation
Upon Termination. In the event of termination of Employee’s employment as set forth herein, and subject to any lawful
right of offset the Company may have against any such benefits, compensation, or severance amounts owed to Employee, whether the
result of promissory notes, loans, or other financial arrangements the Company may have entered into with or on the Employee’s
behalf, and which are or would become due and payable on or after the termination date, to include the principal and interest pursuant
to such arrangements (which right of offset cannot be inconsistent with the standards for nonqualified deferred compensation plans
under Code Section 409A, to the extent applicable), the Parties agree that the following terms shall be the exclusive severance
arrangements:

 

5.6.1         In
the event of termination of Employee's employment by the Company for Cause pursuant to Section 5.1 or unilateral termination by
the Employee pursuant to Section 5.3, the Company's obligation to pay and provide Employee compensation and benefits under this
Agreement shall immediately terminate, except: (a) Employee shall be entitled to receive that portion of his then Base Salary which
shall have been earned through the termination date; and (b) the Company shall pay or provide Employee such other payments and
benefits, if any, which had accrued hereunder before the termination date. Other than the foregoing, the Company shall have no
further obligations to Employee under this Agreement.

 

    	-4-

    	 

    

 

5.6.2           In
the event the Company terminates Employee's employment without Cause pursuant to Section 5.2 or Employee terminates for Good Reason
pursuant to Section 5.4 within thirty (30) calendar days of the expiration of the Good Reason Cure Period , at any time other than
the two (2) year period immediately following a "Change in Control," the Company's obligation to pay and provide Employee
compensation and benefits under this Agreement shall immediately terminate, except: (a) Employee shall be entitled to receive that
portion of his then Base Salary which shall have been earned through the termination date; (b) the Company shall pay to Employee,
within thirty (30) calendar days following the date of termination, a lump sum amount equal to fifty-five percent (55%) of the
product of (i) times (ii), where (i) is his annual Base Salary for the fiscal year in which the termination occurs, and (ii) is
a fraction, the numerator of which is the number of days elapsed in such fiscal year through the date of termination and the denominator
of which is 365; (c) the Company shall pay or provide Employee such other payments and benefits, if any, which had accrued
hereunder before the termination date; (d) the Company shall pay to Employee, within thirty (30) calendar days following the
termination date, a lump sum payment in an amount equal to one hundred fifty percent (150%) of Employee's Base Salary for the fiscal
year in which the termination occurs; (e) the Company shall pay Employee, within thirty (30) calendar days following the termination
date, a lump sum payment in an amount equal to eighteen (18) times the monthly “COBRA Premium Rate” (which is the monthly
amount charged, as of the termination date, for COBRA continuation coverage under the Company's group medical and dental plans
for the coverage options and coverage levels applicable to Employee and his covered dependents immediately prior to the termination
date); (f) with respect to Company stock options granted after the date of this Agreement, Employee would immediately vest in any
option that would have vested within twelve (12) months of Employee’s termination date had Employee not been terminated,
and such option may be exercised pursuant to the provisions of the then current Company Stock Option and Incentive Plan (“Stock
Option Plan”) as if the option were vested at the date of termination; and (g) all shares of restricted stock granted
to the Employee after the date of this Agreement, which are not intended to qualify as “performance based compensation”
under Section 162(m) of the Code shall contain provisions which shall provide for immediate vesting upon Termination without Cause
or for Good Reason.  Payment of the severance compensation described in subpart (d) and (e) of this
Section 5.6.2 is subject to the requirements of Sections 5.8 and 5.9. Other than the foregoing, the Company shall have no further
obligations to Employee under this Agreement.

 

5.6.3           In
the event Employee's employment is terminated as a result of Employee's Death or Disability pursuant to Section 5.5, the Company's
obligation to pay and provide the Employee compensation and benefits under this Agreement shall immediately terminate except: (a)
Employee shall be entitled to receive that portion of his then Base Salary which shall have been earned through the termination
date; and (b) the Company shall pay or provide Employee such other payments and benefits, if any, which had accrued hereunder before
the termination date. Other than the foregoing, the Company shall have no further obligations to Employee under this Agreement

 

    	-5-

    	 

    

 

5.6.4           In
the event of a "Qualifying Termination" within two (2) years immediately following a "Change In Control," then,
in lieu of all other benefits under this Agreement, the Company's obligation to pay and provide Employee compensation and benefits
under this Agreement shall immediately terminate, except: (a) Employee shall be entitled to receive that portion of his then Base
Salary which shall have been earned through the termination date; (b) the Company shall pay or provide Employee such other payments
and benefits, if any, which had accrued hereunder before the termination date; (c) the Company shall pay to Employee in a lump
sum not later than thirty (30) calendar days after the termination date an amount equal to two times one hundred fifty-five percent
(155%) of his annual Base Salary for the fiscal year in which the termination occurs; (d) the Company shall pay Employee, in a
lump sum not later than thirty (30) calendar days after the termination date, an amount equal to eighteen (18) times the COBRA
Premium Rate; (e) the Company shall provide Employee with reasonable and appropriate out-placement services, as determined and
coordinated by the Company, by paying a fee, not to exceed Two Thousand Five Hundred Dollars ($2,500.00), to an outplacement services
provider selected by the Company, provided that such services shall not extend past the end of the second taxable year following
the taxable year in which the Qualifying Termination occurs; and (f) Employee shall be allowed to exercise available stock options
in accordance with the Stock Option Plan as if he were terminated without cause pursuant to the Stock Option Plan. Payment or provision
of the severance compensation or benefits described in subparts (c), (d) and (e) of this Section 5.6.4 is subject to the requirements
of Sections 5.8 and 5.9. Other than the foregoing, the Company shall have no further obligations to Employee under this Agreement.

 

For purposes of this Agreement, a "Qualifying Termination"
shall mean either (i) a unilateral termination of Employee by the Company without Cause pursuant to Section 5.2 or (ii) a
termination by Employee for Good Reason pursuant to Section 5.4 within thirty (30) calendar days of the expiration of the
Good Reason Cure Period.

 

For purposes of this Agreement, "Change In Control"
of the Company shall mean and shall be deemed to have occurred as of the first day any one or more of the following conditions
shall have been satisfied:

 

(A)         The
acquisition, within a 12-month period ending on the date of the most recent acquisition, by any individual, entity or group (within
the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")
(a "Person") of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act as in
effect from time to time) of thirty percent (30%) or more of either (i) the then outstanding shares of common stock of the
Company or (ii) the combined voting power of the then outstanding voting securities of the Company entitled to vote generally
in the election of directors; provided, however, that the following acquisitions shall not constitute an acquisition of control:
(a) any acquisition directly from the Company (excluding an acquisition by virtue of the exercise of a conversion privilege),
(b) any acquisition by the Company, (c) any acquisition by any employee benefit plan (or related trust) sponsored or
maintained by the Company or any corporation controlled by the Company, (d) any acquisition by any corporation pursuant to
a reorganization, merger or consolidation, if, following such reorganization, merger or consolidation, the conditions described
in clauses (i), (ii) and (iii) of subsection (C) of this Section 5.6.4 are satisfied, (e) any acquisition
by any Person who, immediately before the commencement of the 12-month period, already held beneficial ownership of thirty percent
(30%) or more of the outstanding voting securities of the Company ("Affiliated Person") or (f) upon the death of any
shareholder who, on the date of this Agreement, is the beneficial owner of 10% or more of the outstanding voting securities of
the Company, any acquisition triggered by the death of such shareholder by operation of law, by any testamentary bequest or by
the terms of any trust or other contractual arrangement established by such shareholder; or

 

    	-6-

    	 

    

 

(B)         Individuals
who, as of the date hereof, constitute the Board of Directors of the Company (the "Incumbent Board") cease for any reason
to constitute at least a majority of the Board of Directors of the Company (the "Board"); provided, however, that any
individual becoming a director subsequent to the date hereof whose election, or nomination for election by the Company's shareholders,
was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though
such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption
of office occurs as a result of either an actual or threatened election contest (as such terms are used in Rule 14a-11 of
Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or
on behalf of a Person other than the Board; or

 

(C)         Approval
by the shareholders of the Company of a reorganization, merger or consolidation, in each case, unless, following such reorganization,
merger or consolidation, (i) more than fifty percent (50%) of, respectively, the then outstanding shares of common stock of
the corporation resulting from such reorganization, merger or consolidation and the combined voting power of the then outstanding
voting securities of such corporation entitled to vote generally in the election of directors is then beneficially owned, directly
or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners, respectively, of the
outstanding Company common stock and outstanding Company voting securities immediately prior to such reorganization, merger or
consolidation in substantially the same proportions as their ownership, immediately prior to such reorganization, merger or consolidation,
of the outstanding Company stock and outstanding Company voting securities, as the case may be, (ii) no Person (excluding
the Company, any employee benefit plan or related trust of the Company or such corporation resulting from such reorganization,
merger or consolidation and any Person beneficially owning, immediately prior to such reorganization, merger or consolidation,
directly or indirectly, thirty percent (30%) or more of the outstanding Company common stock or outstanding voting securities,
as the case may be) beneficially owns, directly or indirectly, thirty percent (30%) or more of, respectively, the then outstanding
shares of common stock of the corporation resulting from such reorganization, merger or consolidation or the combined voting power
of the then outstanding voting securities of such corporation entitled to vote generally in the election of directors and (iii) at
least a majority of the members of the board of directors of the corporation resulting from such reorganization, merger or consolidation
were members of the Incumbent Board at the time of the execution of the initial agreement providing for such reorganization, merger
or consolidation; or

 

    	-7-

    	 

    

 

(D)         Approval
by the shareholders of the Company of (i) a complete liquidation or dissolution of the Company or (ii) the sale or other disposition
of all or substantially all of the assets of the Company, other than to a corporation with respect to which following such sale
or other disposition (a) more than fifty percent (50%) of, respectively, the then outstanding shares of common stock of such
corporation and the combined voting power of the then outstanding voting securities of such corporation entitled to vote generally
in the election of directors is then beneficially owned, directly or indirectly, by all or substantially all of the individuals
and entities who were the beneficial owners, respectively, of the outstanding Company common stock and outstanding Company voting
securities immediately prior to such sale or other disposition in substantially the same proportion as their ownership, immediately
prior to such sale or other disposition, of the outstanding Company common stock and outstanding Company voting securities, as
the case may be, (b) no Person (excluding the Company and any employee benefit plan or related trust of the Company or such
corporation, any Affiliated Person and any Person beneficially owning, immediately prior to such sale or other disposition, directly
or indirectly, thirty percent (30%) or more of the outstanding Company common stock or outstanding Company voting securities, as
the case may be) beneficially owns, directly or indirectly, thirty percent (30%) or more of, respectively, the then outstanding
shares of common stock of such corporation and the combined voting power of the then outstanding voting securities of such corporation
entitled to vote generally in the election of directors and (c) at least a majority of the members of the board of directors
of such corporation were members of the Incumbent Board at the time of the execution of the initial agreement or action of the
Board providing for such sale or other disposition of assets of the Company.

 

Notwithstanding any other provision of this Section
5.6.4 to the contrary, an occurrence shall not constitute a Change in Control if it does not constitute a change in the ownership
or effective control of, or in the ownership of a substantial portion of the assets of, the Company, within the meaning of Code
Section 409A(a)(2)(A)(v) and its interpretive regulations.

 

5.7           Payroll
Withholdings. The Company may withhold from any compensation or benefits payable under this Agreement all federal, state,
city, or other taxes or deductions as may be required pursuant to any law or governmental regulation or ruling.

 

    	-8-

    	 

    

 

5.8           Compliance
With Post-Employment Restrictions. If Employee breaches, or threatens to breach any of the covenants or provisions set
forth in Sections 6 and 7 of this Agreement, then in such event the Company shall have the right immediately and permanently to
discontinue payment and provision of any of the severance compensation and benefits payable under this Agreement. The Employee
and Company acknowledge and agree that such remedy is in addition to, and not in lieu of, any and all other legal and/or equitable
remedies that may be available to the Company in connection with the Employee's breach or threatened breach of any of the covenants
or provisions of this Agreement.

 

5.9           Release
Agreement. As a condition of receiving the severance benefits described in Sections 5.6.2(c), 5.6.2(d), 5.6.4(c), 5.6.4(d),
or 5.6.4(e), Employee will be required to sign a standard release agreement acceptable to the Company in which he releases and
waives all claims which he may have against the Company or any affiliate, employee, shareholder, officer, director, agent or representative
of the Company (except for his rights under this Agreement or any other vested rights Employee may have under any insurance, pension,
employee stock ownership or stock option plans sponsored or made available by the Company). The Company will provide such release
agreement to Employee at the termination of Employee's employment with the Company. As part of the release agreement, Employee
will be required (a) to agree to cooperate with the Company with respect to any business matters about which he has knowledge,
including any litigation or threatened litigation, (b) agree not to cooperate with any claimants against the Company unless required
by law to do so, (c) agree not to make any negative or derogatory comments about the Company or its executives and (d) affirm his
post-termination obligations under this Agreement, including without limitation the obligations set forth in Sections 6 and 7.

 

5.10         Delay
of Separation Payments to Specified Employee. Notwithstanding any other provisions of this Agreement, if any amount payable
to Employee under this Agreement on account of Employee’s separation from service with the Company constitutes deferred compensation
within the meaning of Code Section 409A, and Employee is a specified employee, within the meaning of Code Section 409A(a)(2)(B)(i),
on the date of his separation from service, payment of the amount shall be delayed until the first business day that is at least
six (6) months after the date on which Employee’s separation from service occurred.

 

6.            Non-competition.

 

6.1           General.
Employee acknowledges that his position with the Company is special, unique and intellectual in character and his position in the
Company places him in a position of confidence and trust with employees and customers of the Company. Employee further acknowledges,
recognizes, and represents receipt of sufficient consideration for these restraints in the form of the Base Salary and other valuable
consideration contained herein. The restrictions and obligations contained in this Section 6 shall survive the Term of this Agreement.
Notwithstanding the above, if the Company terminates, or elects not to renew this Agreement, and subsequently terminates Employee’s
employment without the payment of severance payments equivalent to 100% of Employee’s Base Salary in effect at the time of
termination, which shall be payable in lump sum, the Employee will not be subject to the restrictions and obligations of this Section
6.

 

    	-9-

    	 

    

 

6.2           Non-competition.
Employee agrees that during his employment with the Company and for a period of one (1) year immediately after the termination
of Employee’s employment with the Company (if but only if this Agreement was in effect at the time of such termination),
thereafter Employee shall not:

 

6.2.1         Either
alone or in concert with others, whether as director, officer, consultant, principal, employee, agent or otherwise, engage in or
contribute Employee’s knowledge and abilities to any business or entity in competition with the Company (“Competing
Business”);

 

6.2.2         Be
employed by, work for, consult with, or act in any other capacity for, any person or entity that is engaged in any Competing Business
if in such employment, work or capacity Employee likely would, because of the nature of his position with, or work for, the competitor
and his knowledge of the Company's Confidential Information, inevitably use and/or disclose any of the Company's Confidential Information
in his work for or with such competitor;

 

6.2.3         Solicit,
recruit, hire, employ or attempt to hire or employ any person who is then or within the proceeding one (1) year period was, an
employee of the Company, or otherwise urge, induce or seek to induce any person to terminate his/her employment with the Company;

 

6.2.4         Solicit,
urge, induce or seek to induce any of the Company's independent contractors, subcontractors, vendors, suppliers, customers or consultants
to terminate their relationship with, or representation of, the Company or to cancel, withdraw, reduce, limit or in any manner
modify any such person's or entity's business with or representation of, the Company for whatever purpose or reason;

 

6.2.5         Take
any action intended to harm the Company or its reputation, which the Company reasonably concludes could lead to unwanted or unfavorable
publicity to the Company;

 

6.2.6         The
restrictive time periods set forth in this Section 6.2 shall not expire during any period in which Employee is in violation of
any of the restrictive covenants set forth in this Section 6.2, and all restrictions shall automatically be extended by the period
Employee was in violation of any such restrictions;

 

    	-10-

    	 

    

 

6.2.7           The
restrictive covenants contained in this Section 6.2 prohibit Employee from engaging in certain activities directly or indirectly,
whether on his own behalf or on behalf of any other person or entity.

 

6.2.8           The
covenants and restrictions in this Section 6.2 are separate and divisible, and to the extent any covenant, provision or portion
of Section 6.2 is determined to be unenforceable or invalid for any reason, such unenforceability or invalidity shall not affect
the enforceability or validity of the remainder of the Agreement. Should any particular covenant, restriction, provision or portion
of Section 6.2 be held unreasonable or unenforceable for any reason, including, without limitation, the time period, geographical
area, and/or scope of activity covered by any restrictive covenant, provision or clause, such covenant, provision or clause shall
automatically be deemed reformed such that the contested covenant, provision or portion will have the closest effect permitted
by applicable law to the original form and shall be given effect and enforced as so reformed to the extent reasonable and enforceable
under applicable law.

 

6.3              Definition
of “Competing Business”: The term “Competing Business” shall mean:

 

6.3.1           The
retail footwear business of Collective Brands, Inc.; Brown Shoe Company, Inc.; Designer Shoe Warehouse; Rack Room (dba); Kohls
Corporation; Shoe Station (dba); Shoe City (dba); Shoe Pavilion, Inc., Shoe Department; Finish Line, Inc.; Foot Locker, Inc.; Dick’s
Sporting Goods, Inc.; The Sports Authority, Inc.; Off Broadway Shoe Warehouse; and their subsidiaries, and any other company which
sells footwear at retail to consumers within 25 miles of any Company store at price points competitive, or likely to be competitive,
with the Company, where the footwear sales of such other company constitute at least fifteen percent (15%) of such company's annual
revenues.

 

6.3.2           Ownership
of an investment of less than 5% of any class of equity or debt security of a publicly-held Competing Business shall not constitute
ownership or participation in violation of the above.

 

6.4              Acknowledgment
Regarding Restrictions. Employee acknowledges and agrees that he understands the restrictions in Section 6, and that
they are reasonable and enforceable, in view of, among other things, the Employee’s position within the Company, the highly
competitive nature of the Company's business, and the confidential nature of the information the Employee has been provided. Employee
further agrees that the Company would not have adequate protection if Employee were permitted to work for its competitors in violation
of the terms of this Agreement since the Company would be unable to verify whether its Confidential Information was being disclosed
and/ or misused, and whether Employee was involved in diverting the Company’s customers and/or its customer goodwill.

 

    	-11-

    	 

    

 

6.5           Disclosures
Concerning New Employment. Employee agrees that he (a) will immediately, within ten (10) days, notify the Company in writing
of his employment, engagement or other affiliation with any other business or entity during the two (2) years immediately following
the termination of Employee's employment with the Company and (b) will provide a copy of Section 6 and 7 of this Agreement to any
prospective employer before accepting employment or other work engagement with any such employer.

 

7.            Confidential
or Proprietary Information

 

7.1           Confidentiality.
As used in this Agreement, the term "Confidential Information" means any and all of the Company's trade secrets, confidential
and proprietary information and all other information and data of the Company that is not generally known to third persons who
could derive economic value from its use or disclosure, including, without limitation, the Company's profile of prospective or
current vendors or customers, business methods and structure, details of the Company's contracts and business matters, employee
compensation, personnel information, marketing strategies and plans, business plans, pricing information and strategies, costs
information, and financial data, whether or not reduced to writing or other tangible medium of expression, including work product
created by Employee in rendering services to the Company. During his employment with the Company and thereafter, Employee will
not use or disclose to others any of the Confidential Information except as authorized in writing by the Company or in the performance
of work assigned Employee by the Company. Employee also will abide by the Company's policies protecting the Confidential Information.
Employee's confidentiality obligations shall continue as long as the Confidential Information remains confidential, and shall not
apply to information which becomes generally known to the public through no fault or action of Employee. Employee agrees that the
Company owns the Confidential Information and Employee has no rights, title or interest in any of the Confidential Information.
At the Company's request or upon termination of Employee's employment with the Company for any reason, Employee will immediately
deliver to the Company all materials (including all copies and electronically stored data) containing any Confidential Information
in Employee's possession, custody or control.

 

7.2           Trade
Secrets-Developments. All improvements, developments, concepts, and ideas ("Developments") relating to the Company's
business, or capable of beneficial use by the Company, including, but not limited to, marketing, confidential and trade secret
information, techniques, discoveries, slogans, designs, artwork, and writings, which the Employee has made or will make during
his employment with the Company are the sole and exclusive property of the Company without charge to the Company other than the
Employee's compensation.

 

    	-12-

    	 

    

 

7.3           Acknowledgement.
Employee agrees that the restrictions set forth in Sections 7.1 and 7.2 are reasonable and necessary to protect the trade secrets,
confidential information, intellectual property rights and goodwill of the Company. The restrictions and obligations contained
in this Section 7 shall survive the term of this Agreement.

 

8.          Remedies.
In the event of a breach or threatened breach by the Employee of any of the above provisions, the Company shall be entitled to
an injunction restraining Employee from such breach, in addition to all other remedies which the Company shall be entitled to pursue.
The Company also shall be entitled to recover from Employee all litigation costs and attorneys' fees incurred by the Company in
any action or proceeding relating to this Agreement in which the Company prevails, including, but not limited to, any action or
proceeding in which the Company seeks enforcement of this Agreement or seeks relief from Employee's violation of this Agreement.
Nothing herein shall be construed as prohibiting the Company from pursuing any other remedies available for such breach, threatened
breach, or any breach of this Agreement.

 

9.          Survival
of Post-Termination Obligations. Employee acknowledges and agrees that his post-termination obligations under this Agreement,
including without limitation Employee's non-competition and confidentiality obligations set forth in Sections 6 and 7 of this Agreement,
shall survive the termination of Employee's employment with the Company, regardless whether such termination is voluntary or involuntary,
or is with or without Cause.

 

10.         Notices.
All notices, requests, consents, and other communications under this Agreement shall be in writing and shall be deemed to have
been delivered on the date personally delivered or the dated mailed, postage prepaid, by certified mail, return receipt requested,
or telegraphed and confirmed, or faxed and confirmed, if addressed to the respective parties as follows;

 

	To Employee:	Carl N. Scibetta
	 	4252 Birkshire Heights
	 	Fort Mill, South Carolina  29708
	 	 
	To Company:	Chief Executive Officer
	 	Shoe Carnival, Inc.
	 	7500 East Columbia Street
	 	Evansville, Indiana 47715

 

Either party hereto may designate a different address by providing
written notice of such new address to the other party hereto.

 

11.         Waiver.
The failure or delay of the Company at any time or times to require performance of, or to exercise any of its powers, rights or
remedies with respect to, any term or provision of this Agreement or any other aspect of Employee’s conduct or employment
shall not affect the Company’s right to later enforce any such term or provision.

 

    	-13-

    	 

    

 

12.         Assignment.
The Company shall have the right to assign this Agreement. This Agreement shall inure to the benefit of, may be enforced by, and
shall be binding on, any and all successors and assigns of the Company, including, without limitation, by asset assignment, stock
sale, merger, consolidation or other corporate reorganization, and shall be binding on Employee, his executors, administrators,
personal representatives and other successors in interest. Employee shall not have the right to assign this Agreement nor any of
his rights, powers, duties or obligations hereunder.

 

13.         Code
Section 409A Standards. This Agreement, and all other nonqualified deferred compensation plans in which the Employee participates,
are intended to comply with the standards for nonqualified deferred compensation plans established by Code Section 409A and its
interpretive regulations and other regulatory guidance (the “Section 409A Standards"), to the extent applicable, and
this Agreement shall be construed accordingly. In construing or interpreting any vague or ambiguous provisions of this Agreement,
the interpretation that will prevail is the interpretation that will cause this Agreement to comply with the Section 409A Standards.
Any provision of this Agreement, or any deferred compensation provided under it, that would fail to satisfy the Section 409A Standards
shall not have any force or effect until it is amended to comply with the applicable Section 409A Standards, which amendment may
be retroactive to the extent permissible under the Section 409A Standards.

 

14.         Entire
Agreement. This Agreement cancels and supersedes all prior negotiations, discussions, commitments and understandings between
the parties relating hereto, whether oral or written. This Agreement embodies the entire agreement and understanding between such
parties with respect to the matters covered hereby. Neither party shall be bound by any term or condition other than as is expressly
set forth herein.

 

15.         Amendment.
This Agreement may be amended only by an instrument in writing executed by the parties hereto.

 

16.         Governing
Law: Forum Selection. This Agreement shall be construed and enforced in accordance with and governed by the laws of the
State of Indiana, without regard to the conflicts of law rules thereof. Any legal action relating to this Agreement shall be commenced
and maintained exclusively before any appropriate state court of record in Vanderburgh County, Indiana, or, if necessary because
of a federal question mandating jurisdiction in the federal courts is involved, the United States District Court for the Southern
District of Indiana, Evansville Division, and the parties hereby submit the jurisdiction of such courts and waive any right to
challenge or otherwise raise questions of personal jurisdiction or venue in any action commenced or maintained in such courts.

 

17.         Severability.
The parties intend that the provisions of this Agreement shall be enforced to the fullest extent permissible under the applicable
law. Should any provision of this Agreement be unenforceable or invalid for any reason, such unenforceability or invalidity shall
not affect the enforceability or validity of the remainder of the Agreement.

 

    	-14-

    	 

    

 

IN WITNESS WHEREOF, the parties hereto have
executed this Employment and Noncompetition Agreement on this 4th day of December, 2012.

 

	SHOE CARNIVAL, INC.: "Company"	 	CARL N. SCIBETTA: "Employee"
	 	 	 
	By: 	/s/Clifton E. Sifford	 	/s/Carl N. Scibetta
	 	 	 
	Its: 	President & CEO	 	 

 

    	-15-ex10-7.htm

 

Exhibit 10.7

 

Product Research and Development Agreement

 

Party A: Shaanxi Aoxing Pharmaceutical Co. Ltd.

 

Party B: Life Science Academy of Northwest University

 

Party A and Party B reached the following R&D agreement regarding National Type I new medicine Danshensu Borneol Ester through friendly negotiation:

 

1.   Project Name: R&D of National Type I new medicine Danshensu Borneol Ester (DBZ)

 

2.   Project research progress:

 

(1)   Party B has finished the research of DBZ’s activity, technical, quality standard and stability.

 

(2)   Party B designed and composed DBZ, DBZ structure, compose technical which have the proprietary intellectual property rights with National Patent Protection (Patent No.ZL200610042787.3). It has submitted the International Patent application PCT (PCT/CN2007/0011550)

 

(3)   DBZ can be developed as 1st type chemical new medicine treatment for Ischemic cerebrovascular disease which has the proprietary intellectual property rights.

 

3.   Intent of cooperation

 

(1)   According to the market research of China Ischemic cerebrovascular disease by Party A, DBZ products have broad market prospect.

 

(2)   Since Party B lack of research funding, Party B are willing to transfer DBZ patent products 60% equity. The proceed will use for the expenses of following: products pre-research expense compensation, mid-experiment research, Pharmacological and toxicological study, Clinical study of 1,2,3,4 period, application for new medicine.

 

(3)   Both parties agree to cooperate, R&D, produce DBZ together. After the product is approved production, Party B agree that Party A as the sole producer and seller. The profit after tax will split according to 6:4 (Party A 60%, Party B 40%).

 

(4)   After Party B transfer the production right to Party A, Party A has the sole license number in China. Party A cannot transfer this patent product to any third party.

 

(5)   Both Parties can jointly apply for National research funding. 60% of the funding will be the investment of Party A.

 

4.   Project transfer fee and payment term:

 

(1)   Both Parties agreed that the market value of the project should be 120 million RMB.

 

Party A hold 60% that is 72 million which covers all expenses before the production. Party B ’s technology hold 40%.

 

(2)   Party A’s payment term:

 

a.    Party A pays 15 million RMB as the deposit within 20 working days after sign the agreement. Party B cannot make arrangement with any other third party. After receiving the payment, both party report project together to start the Pharmacodynamics, pharmacology, toxicology research and finish the documents research before the clinic.

 

b.    Party A pay 20 million RMB before Jan.15, 2012 as 1st and 2nd clinic research expense.

 

c.    Party A pay 20 million RMB before Jan.15, 2013 as 3rd and 4th clinic research expense.

 

d.    Party A pay 17 million RMB before Jan.15, 2014 as product application expense.

 

e.    The yearly national research funding will be deducted from next year payment.

 

 

 

 

 

5.   Party B promise to undertake:

 

(1)   make the DBZ product as national 1st type chemical new medicine and make sure the product R&D success.

 

(2)   Will not transfer to any third party. Party A has priority when it has overseas cooperation opportunity. Party A can sign cooperation agreement on behalf of Party B.

 

(3)   If Party B willing to transfer the technique equity, Party A has priority to take over.

 

(4)   Agree DBZ product patent use as Party A enterprise publicity to expand the sales.

 

6.   Liability for Breach Contract

 

(1)   Party A:

 

a.    The payment cannot make in the middle of the research. Party B has the right to transfer his equity to third party after 30 days of written notice.

 

b.    The payment cannot make within 50 days of signing the agreement. Party B  has the right to terminate the agreement.

 

(2)   Party B:

 

a.    Breach of this agreement term 5.1, Party A can deduct 10 million RMB from the research expenses for each lower level. If the product classified as 7th as or lower than 7th type, Party B should return Party A 3 million RMB. The rest 12 million RMB will be the research expenses of Party B, Party A also hold 60% of DBZ equity.

 

b.    If the DBZ product R&D fail, Party B should return Party A 60% of investment and pay Party A 10 million RMB for penalty.

 

c.    Once product R&D succeed, Party B breach this agreement term 5.2, Party B should return all party A investment and pay Party A 15million RMB for penalty. Party A still hold DBZ 60% equity.

 

7.   Miscellaneous

 

(1)   Both parties cannot revise the agreement under any circumstance.

 

(2)   Matters not covered in this agreement, the two sides should resolve through consultation.

 

(3)   After 60 days of Party B receive 15 million RMB from Party A, the two sides should sign formal contract.

 

(4)   This agreement has 4 duplicates. The agreement entry into force after signed and sealed by both parties.

 

 

Party A: Shaanxi Aoxing Pharmaceutical Co. Ltd.

 

 

Representative:

 

Date: Dec.15, 2012

 

 

Party B: Life Science Academy of Northwest University

 

 

Representative:

 

Date: Dec.16, 2012

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00215-of-00352.parquet"}]]